BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 20, 2018
View Archived Issues
Identification and preclinical characterization of ABX-1431, inhibitor of monoacylglycerol lipase
Read More
New type of neuronal insulation discovered
Read More
Sleeper HIV can be napping or conked out
Read More
NOXA gives leg up to BCL-2 inhibition
Read More
Immunocore and Genentech enter partnership to codevelop IMC-C103C
Read More
NLRP3 antagonist IFM-514 shows promise in mouse models of NASH
Read More
SNACing on peptides: findings may allow oral delivery of peptides
Read More
Nash Pharmaceuticals reports data on NP-135 in mouse model of kidney fibrosis
Read More
Aurigene's small molecule antagonist targets both PD-L1 and TIGIT pathways
Read More
Rocket Pharmaceuticals announces FDA clearance of IND for RP-L201 gene therapy
Read More
First patients dosed in phase I OPTIC study of ADVM-022 gene therapy in wet AMD
Read More
First-in-human results presented for NGM-313 in insulin-resistant obese patients with fatty liver
Read More
Samumed doses first subject in phase II/III study of SM-04554
Read More
First patient dosed in first-in-human study of NJA-730
Read More
French approvals to begin phase II trial of Tedopi and Opdivo in pancreatic cancer
Read More
Lunan Pharmaceutical Group presents IDO1 inhibitors
Read More
Denali reports promising phase I outcomes with RIPK1 inhibitor DNL-747
Read More
New DAT inhibitors may improve effort-related motivation dysfunction
Read More
Sentinel Oncology divulges PLK1 inhibitors
Read More
Interim phase I results show VLA-1601 induces neutralizing antibodies against Zika virus
Read More
Phase III trial of STAGR-320 in house dust mite-induced allergic rhinitis meets primary endpoint
Read More
Aviara Pharmaceuticals discloses ITGA4 and LPAM-1 antagonists
Read More
Machavert to use grant award to support RAL GTPase inhibitor development
Read More
Phase I data on BLU-5937 support progression to phase II for chronic cough
Read More
Ohara Pharmaceutical identifies anticancer agents
Read More
NIH grant supports IBBR's development of antibody therapeutic against HIV-1
Read More
Lupin identifies hSTING agonists for cancer and infections
Read More
GeoVax collaborates with Leidos on immunotherapy research program
Read More
CPI-818 demonstrates promising safety and efficacy in dogs with T-cell lymphoma
Read More
AZD-3229 demonstrates efficacy in preclinical models driven by KIT gene mutations
Read More
RSK3 inhibition by gene therapy reduces cardiac dysfunction after myocardial infarction in mice
Read More